News
Stocks rebounded on Wednesday after President Donald Trump denied reports that he was close to ousting Powell as chairman of ...
Former deputy Treasury Secretary Roger Altman said he did not think Jerome Powell would agree to leave if the president asked ...
Stocks rebounded on Wednesday after President Donald Trump denied reports that he was close to ousting Powell as chairman of ...
Wolfe Research reaffirmed its ‘Outperform’ rating on UnitedHealth Group but cut its price target to $330 from $363, citing ongoing medical billing pressures. The firm highlighted that UnitedHealth’s ...
1d
Fintel on MSNWolfe Research Downgrades Realty Income (O)Fintel reports that on July 15, 2025, Wolfe Research downgraded their outlook for Realty Income (NYSE:O) from Outperform to ...
2d
Fintel on MSNWolfe Research Downgrades HF Sinclair (DINO)Fintel reports that on July 14, 2025, Wolfe Research downgraded their outlook for HF Sinclair (NYSE:DINO) from Peer Perform ...
Centene Corporation (NYSE:CNC) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On July 2, Wolfe ...
Shares of MongoDB (MDB) rose about 2% on Wednesday after Wolfe Research began coverage on the database software company with ...
Overall, Wolfe favors a mix of growth and value as the second half of 2025 begins. Related articles Wolfe Research refreshes high-conviction ideas heading into H2 ...
The research firm reiterated the company’s solid position amid the “TTR craze” while also echoing its commercial execution strategy. Wolfe Research Initiates Coverage of BridgeBio Pharma ...
Fintel reports that on May 13, 2025, Wolfe Research upgraded their outlook for Insulet (BMV:PODD) from Peer Perform to Outperform.
Wolfe Research restated their peer perform rating on shares of AZEK (NYSE:AZEK – Free Report) in a research report sent to investors on Wednesday, Marketbeat reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results